Bowel Cancer Awareness
ColoAlert: At-Home Bowel Cancer Screening Test
Earlier answers
The conversation that saves lives is the one we keep avoiding.
A simple stool test that looks for the earliest signs of bowel cancer — from home.
Collect a small sample at home, post it to the lab, and get your results securely.
• Collect at home in about 5 minutes
• Combines stool-DNA markers with a haemoglobin (FIT) test
• Analysed by Biovis, an ISO 15189-accredited European laboratory
• Results in 10–14 days
The reality
A disease defined by timing
Bowel cancer is the UK's fourth most common cancer and its second-biggest cancer killer after lung cancer. Sources: Cancer Research UK, Bowel Cancer UK, Pall Mall Medical.
42,000+
new cases of bowel cancer in the UK every year
120
people diagnosed in the UK every single day
46
lives lost to bowel cancer each day
9 in 10
survive when it's caught at the earliest stage
Who it’s for
ColoAlert may suit you if you’re under 50 and outside NHS screening; want testing between NHS rounds; have a family history of bowel cancer or polyps; or want a more thorough at-home option than a standard FIT. This is a screening test, not a diagnosis, and does not replace advice from your doctor. If you have symptoms that worry you, contact your GP or call 111 — don’t wait for a test result.
How it works
1. Order online.
2. Collect a small stool sample at home (about 5 minutes, no diet change).
3. Post to the lab in the prepaid packaging.
4. Get your report in 10–14 days.
What it measures: ColoAlert combines analysis of tumour-DNA markers shed into stool with a faecal immunochemical (haemoglobin) test, so it can flag cancers a blood-only test may miss.
Q: Is ColoAlert available on the NHS?
A: No — the NHS uses a FIT kit for ages 50 to 74. ColoAlert is private and available at any age.
Q: Do I need diet or medication changes? A: No special diet is needed. Q: What if my result is positive? A: See your GP to arrange a colonoscopy.
Q: How much does it cost and how fast are results?
A: £324.99, results in 10–14 days.
If your symptoms are persistent, don't presume the worst — but don't ignore them either. Talk to your GP. If you're over 60, eat a lot of processed meat, or have a family history of bowel cancer, your risk is higher and earlier checks matter more.
Services We Provide
_jfif.jpg)
Nonacus Clinical Services (UK Partner)
Specialism:
Genomics & Hereditary Cancer
Description:
Birmingham-based specialist genomics laboratory operating as Informed Genomics Limited, trading as Nonacus Clinical Services. Nonacus provides MeCheck’s hereditary cancer panel testing, bladder cancer (GALEAS®) liquid biopsy analysis, and molecular genomics services.
Accreditations:
-
UKAS ISO 15189:2022
-
Schedule No. 22262
-
ISO 27001 Data Security
-
GDPR Compliant
-
ACMG / ACGS Variant Guidelines
Footnote:
Accreditation issued by the United Kingdom Accreditation Service (UKAS) — the sole national accreditation body recognised by the British Government. Accreditation assessed annually.
.png)
Biovis Diagnostik MVZ GmbH (Germany Partner)
Specialism:
Bowel Cancer Screening
Description:
Specialist medical laboratory based in Limburg-Eschhofen, Germany, with over a decade of expertise in stool diagnostics, microbiome analysis, and cancer screening. Biovis provides MeCheck’s bowel cancer (ColoAlert®) testing services.
Accreditations:
-
DAkkS ISO 15189:2024
-
DIN EN ISO 15189
-
Stool Diagnostics Specialist
-
EQA Scheme Participant
Footnote:
Accreditation issued by Deutsche Akkreditierungsstelle (DAkkS) — Germany’s national accreditation body, operating under EU Regulation 765/2008. Equivalent in standing to UKAS accreditation in the UK.
_edited.png)
Bloodo / LifeLab1 (Lithuania Partner)
Specialism:
NAD, NMN & Cellular Wellness
Description:
Bloodo is a Vilnius-based clinical diagnostics company operating LifeLab1, a fully licensed clinical laboratory specialising in dried blood spot (DBS) testing, liquid chromatography/mass spectrometry (LC/MS), and advanced metabolic biomarker analysis. Bloodo provides MeCheck’s NAD and NMN cellular wellness testing services.
LifeLab1 maintains quality standards aligned with ISO 15189 and participates in international external quality assurance (EQA) programmes to ensure consistent, reliable results. The laboratory team comprises experienced medical biologists, quality specialists, PhD candidates, and doctors of pharmacy. Collaborative research is conducted with Vilnius University (Lithuania) and Malmö University (Sweden).
Licences and standards:
-
ISO 15189 Aligned
-
CE Marked · IVDR 2017/746
-
EN ISO 13485 Manufacturing
-
LHP-2819 Licensed
-
NR-4864 State Accredited
-
NM-334 Licensed
Footnote:
Regulated by Lithuanian state health authorities and the Lithuanian National Accreditation Bureau (LA) — a full ILAC MRA signatory and member of the European Accreditation (EA) network.
Additional standards
CE / IVDR — Clinically Validated Test Kits:
All test kits supplied by MeCheck carry CE marking under the EU In Vitro Diagnostic Regulation (IVDR), confirming they meet rigorous safety, performance, and clinical validity requirements before reaching consumers.
Clinical Review — Medically Reviewed Results:
All products are assessed for clinical appropriateness by Dr Tang before listing. Results are benchmarked against current clinical reference ranges and provided with clear, actionable guidance.